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Identifying Predictors of High Sodium Excretion in Patients with Heart Failure: A
Mixed Effect Analysis of Longitudinal Data
Abstract
BACKGROUND: A low-sodium diet is a core component of heart failure self-care but patients have
difficulty following the diet.
AIM: The aim of this study was to identify predictors of higher than recommended sodium excretion
among patients with heart failure.
METHODS: The World Health Organization Five Dimensions of Adherence model was used to guide
analysis of existing data collected from a prospective, longitudinal study of 280 community-dwelling
adults with previously or currently symptomatic heart failure. Sodium excretion was measured objectively
using 24-hour urine sodium measured at three time points over six months. A mixed effect logistic model
identified predictors of higher than recommended sodium excretion.
RESULTS: The adjusted odds of higher sodium excretion were 2.90, (95% confidence interval (CI):
1.15-4.25, pp=0.007) for patients with diabetes; and 2.22 (95% CI: 1.09-4.53, p=0.028) for patients who
were cognitively intact.
CONCLUSION: Three factors were associated with excess sodium excretion and two factors, obesity and
diabetes, are modifiable by changing dietary food patterns.
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Abstract
Background—A low-sodium diet is a core component of heart failure self-care but patients have
difficulty following the diet.
Aim—The aim of this study was to identify predictors of higher than recommended sodium
excretion among patients with heart failure.
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Methods—The World Health Organization Five Dimensions of Adherence model was used to
guide analysis of existing data collected from a prospective, longitudinal study of 280 communitydwelling adults with previously or currently symptomatic heart failure. Sodium excretion was
measured objectively using 24-hour urine sodium measured at three time points over six months.
A mixed effect logistic model identified predictors of higher than recommended sodium excretion.
Results—The adjusted odds of higher sodium excretion were 2.90, (95% confidence interval
(CI): 1.15–4.25, p<0.001) for patients who were obese; 2.80 (95% CI: 1.33–5.89, p=0.007) for
patients with diabetes; and 2.22 (95% CI: 1.09–4.53, p=0.028) for patients who were cognitively
intact.
Conclusion—Three factors were associated with excess sodium excretion and two factors,
obesity and diabetes, are modifiable by changing dietary food patterns.
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Introduction
Heart failure is a major public health concern because it is associated with high morbidity,
mortality and cost. Self-care is recognized as a means of improving these outcomes.1
Consuming a low-sodium diet is one of the most frequently recommended self-care
behaviors; 2–5 however, it is estimated that only 22–55% of patients with heart failure are
adherent to a low-sodium diet.6–8 The rationale for not consuming excessive sodium is that
it can lead to fluid retention, higher ventricular filling pressures and symptoms of
congestion9—all of which put patients with heart failure at risk for acute decompensation
and hospitalization.10,11

Author Manuscript

The general recommendation for all adults in the United States is to consume less than 2300
mg of sodium a day; however, the average American consumes approximately 3400 mg of
sodium per day.12 Sodium is one of the primary cations in extracellular fluid. By influencing
the shifting of water between body compartments, it plays an important role in maintaining
body fluid tonicity, blood volume and pressure. The Heart Failure Society of America
(HFSA) guidelines recommend that patients with symptoms of heart failure restrict daily
sodium intake to 2000–3000 mg/ day.6 The most recent 2013 American Heart Association
(AHA) guideline for the management of heart failure recommends sodium restriction
(<3000 mg/day) for patients with stage C and D heart failure.13

Author Manuscript

Patients with heart failure face a number of barriers to effectively quantifying sodium intake
and maintaining a low-sodium diet. A major barrier is that many patients do not find lowsodium foods palatable and consequently never adjust to the taste of low-sodium foods and
change their eating habits.14 A lack of knowledge about how to identify high-sodium foods,
even when labeled, is also a barrier for patients.14–17 Few restaurants offer low-sodium
options, which decreases dining out opportunities for socialization with friends.14–16
Overall, there are multiple barriers that can impede patients with heart failure from
consistently following a low-sodium diet.

Author Manuscript

The aim of this study was to identify socio-demographic and clinical characteristics that
predict higher than HFSA-recommended sodium intake, estimated by urinary sodium
excretion, using longitudinal data of patients with heart failure. For the purposes of this
study, we assumed that sodium excretion was a reflection of sodium consumption. The
World Health Organization (WHO) Five Dimensions of Adherence model was used to
identify factors potentially associated with poor dietary adherence.18 This holistic model
acknowledges the multi-dimensionality of adherence including social and economic
conditions, the health care system, as well as condition-, therapy- and patient-related
factors.18 Previously, this model has been used to guide the assessment of medication
adherence in patients with heart failure.19

Methods
Study population
This study was a secondary analysis of data collected in an observational prospective cohort
study of 280 community-dwelling adults with previously or currently symptomatic heart
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failure who were followed over a six-month time period. This study was in compliance with
the Declaration of Helsinki.20 Institutional Review Board approval was obtained from all
three sites and all participants gave written informed consent. The parent study was
conducted to investigate the relationship between excessive daytime sleepiness and heart
failure self-care. The detailed methodology of this study has been reported elsewhere.21 In
brief, this was a prospective cohort study with patients assigned to one of four cohorts based
on excessive daytime sleepiness and cognitive decline. Multiple heart failure self-care
behaviors were measured including eating a low-sodium diet, which was assessed with 24hour urine sodium specimens at three time-points (enrollment, three- and six-months).
Patients with heart failure were prospectively enrolled from three outpatient settings, two in
Pennsylvania and one in Delaware, between 2007 and 2010. The basic eligibility criteria for
participation included: (a) chronic heart failure with prior or current symptoms, (b) ability to
read and speak English, and (c) sufficiently able to complete questionnaires and study
procedures (i.e. adequate cognition, English fluency, ability to read). Patients were ineligible
to participate in the study if they had dementia, as measured by the Telephone Interview for
Cognitive Status22 along with other criteria specified in the parent study.21 Most participants
in this study were followed in specialty heart failure clinics and were on standard medical
therapy. The usual care provided by heart failure specialty clinics was not augmented in this
observational study.
Variables and measures

Author Manuscript

Clinical information (e.g. etiology and type of heart failure, left ventricular ejection fraction
(LVEF), and comorbid illnesses) was abstracted from the medical record by a registered
nurse at each of the three enrollment sites. These nurses were familiar with the unique
electronic medical record systems in their own setting. Each nurse received extensive
training to assure consistency of data collection. The principal investigator assured the
fidelity of the data collection protocol at each site and was available for questions
throughout the study period.
Comorbidities (including diabetes) were scored with the Charlson Comorbidity Index, a
commonly used measure,23 directly from the medical record. In this sample, all patients had
a score of at least one because they all had heart failure. Validity was demonstrated by the
instrument authors when comorbidity scores (categorized as low, medium, and high)
predicted risk of 10-year mortality, complications, health care resource use, length-ofhospital-stay, discharge disposition and cost.23–26
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New York Heart Association (NYHA) functional class was scored Class I–IV by a single
board certified cardiologist using data obtained from a standardized interview.27 Body mass
index (BMI) was calculated based on the patient’s weight at the baseline visit and selfreported height. Detailed information on participants’ medications, with doses, was collected
at each data collection period. Sociodemographic characteristics were self-reported.
Cognition was measured with a battery of neuropsychological tests administered in person
by trained research assistants. The number of tests on which participants scored below their
age-based norm was used as an indicator of cognitive status. Any participant who scored
more than 1.5 standard deviations (SDs) beyond the range of normal on at least two of the
Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.
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paper-and-pencil tests was considered to have mild cognitive decline. For analysis, the
cognition variable was dichotomized to indicate those with or without cognitive impairment.
The details of the neurocognitive battery and methodology for categorizing cognitive status
are reported in detail in the parent study.21
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In this study, dietary sodium intake was approximated using urine sodium excretion. Sodium
is under tight homeostatic control and is only lost from the body as sweat (20–80 mmol/
day), stool (5–10 mmol/day) or urine (1–500 mmol/day).28 Patients with heart failure do not
typically engage in strenuous physical activity; therefore do not lose sodium from heavy
perspiration. Variations in sodium excretion are primarily due to variations in recent sodium
intake.29 In this study, we made the assumption that the 24-hour urinary sodium excretion
samples reflected dietary sodium intake across the study period, consistent with previous
studies.10,30,31 The 24-hour urine collection method has been validated by urine recovery of
oral doses of para-amino benzoic acid 32–34 and the collection procedures followed in the
parent study were consistent with recommendations for collection by the Institute of
Medicine.35
Based on criteria set forth by the 2010 HFSA practice guidelines and published papers, urine
sodium in mmoles was converted to mg (mg= mmole×22.99).5,10 The urine sodium binary
outcome in this study was created using 3000 mg/day 24-hour urine sodium cut-off point for
patients in NYHA Class I/II and a 2000 mg/day 24-hour cut-off point for patients in NYHA
Class III/IV. Expected dietary sodium categories were compared between participants whose
dietary sodium excretion was within recommended levels versus those in higher than
recommended levels.
Procedures

Author Manuscript
Author Manuscript

Data were collected at baseline, three-months, and six-months by research assistants during
home visits. Training for urine specimen collection was provided for the patient and family
member, if available, at the baseline data collection interval. Prior to each subsequent urine
collection, patients were telephoned to remind them and reinforce training for the procedure.
Patients were given urine containers, collection devices, verbal and written instructions
(with pictures) specifying when they should start and finish collecting the urine specimen.
Participants were instructed to start the collection at 08:00, discard that specimen, and
collect the final specimen at 08:00 on the following day. Prior to the patient collecting each
urine specimen, the research assistant inquired about changes in the medication regimen. If
the participant had experienced a recent medication change the collection was delayed for
three days starting from the date the medication was changed. Participants recorded when
their urine sodium collection started and finished. A courier picked up the specimens from
the participant’s homes after the 24-hour sample was completed.
The central laboratory at the Hospital of the University of Pennsylvania analyzed the urine
samples to determine the amount of sodium in each specimen using the ion-selective
electrode method (Beckman LX 20 Chemistry Analyzer, Beckman Coulter, Inc., Fullerton,
California, USA).
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Descriptive statistics were used to calculate frequencies with percentages and means with
standard deviation (SD) for the total sample, urine sodium in g per day, and sodium
consumption. Chi-square and Kruskal-Wallis tests were used to compare baseline
characteristics of binary, categorical and ordinal variables between groups. For the purposes
of between group comparisons, the doses for patients on loop diuretics (n=83) were
converted to furosemide equivalents using the following formula: furosemide 80
mg=torsemide 40 mg=bumetanide 2 mg.36 The other participants on diuretics (n=8) were
prescribed hydrochlorothiazide and compared separately. This method has been used in
other studies.10
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Over the three points of data collection, data on the urine sodium excretion were missing
overall in 23% of the participants (193/840 samples), 19% at baseline, 29% at three-months
and 23% at six-months. Multiple imputations were performed for urinary sodium excretion
and BMI data to account for missing time-varying covariates.37–39 Multiple imputation is a
principled, likelihood-based method using statistical modeling to impute data using the
method of chained equations.40 In short, this method creates 10 copies of the data, as
recommended by Rubin.39 The multiple imputations were based on baseline age, gender,
etiology of heart failure, cognitive status and LVEF and complete data for time-varying
covariates, including NYHA class, BMI and urine sodium excretion. Each dataset was then
analyzed separately.41 Estimates of the parameters of interest were averaged across all the
datasets to give a single, final estimate.41,42 After imputation, data were checked to confirm
reasonable values. Standard errors and 95% confidence intervals (CIs) were estimated by
calculating within and between components of variance using the method of Rubin.39
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To determine predictors of higher than recommended sodium intake, a mixed effect logistic
model with a random intercept was tested for each patient. Adjusted odds ratios (ORs), 95%
CIs and p-values are presented for statistically significant predictors of higher than
recommended sodium intake fit on the imputed data.43 The selection of model covariates
was based on four of the five dimensions of adherence from the WHO conceptual model:
condition, therapy, patient-related factors and social and economic conditions as well as
statistical association with the outcome variable, urine sodium excretion. The final 12
covariates included in the multivariable regression models are presented in Table 1.44
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Two sensitivity analyses were conducted. First, mixed effect logistic estimates were
compared between the complete case and imputed data models. Estimates based on imputed
data were more conservative in terms of effect sizes and had narrower CIs. This was
expected because CIs and model variance depend on the amount of missing data, sample
size and number of imputed datasets.40,45 Second, estimates from the mixed effects logistic
models were confirmed with generalized estimating equations models with robust standard
errors. Data are not shown for these two sensitivity analyses because there were no
significant differences between the models. All data analyses were performed using Stata v.
11.2.46
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Results
This sample of patients with heart failure had a mean age of 62 years (SD=12), was
predominantly male (64%), functionally compromised (77% in NYHA class III or IV) with
a mean LVEF of 35 (SD: 17). Over one-third of the sample had diabetes. Among
participants with diabetes, 60% were also obese. Over two-thirds of the sample had
hypertension, and about 20% had chronic obstructive pulmonary disease. Sample
demographic and clinical characteristics are shown in Table 2. The urine sodium levels were
relatively normally distributed so mean and standard errors are presented. The majority of
the sample was prescribed furosemide or an equivalent loop diuretic.

Author Manuscript

The median and interquartile range values for urine sodium excretion on the complete cases
at all three time points were 2770 mg (1750–3950 mg) at baseline, 2630 mg (1690–4000
mg) at three-months and 2780 mg (1900–3790 mg) at six-months. There was no trend in
sodium excretion across time that would suggest that participants modified their diets in
anticipation of these measurements. We found no difference in the pattern of observed
values for participants with missing data and those with complete observations.
In the final model identifying patient characteristics associated with higher than
recommended sodium intake (Table 3), patients with heart failure who were obese
(BMI>30) had nearly three times higher adjusted odds of consuming more than
recommended sodium intake compared to patients with a normal body weight (BMI<25).
The adjusted odds of sodium intake above recommended level were over two times higher
in patients who were cognitively intact compared to patients with some cognitive
impairment. Patients with heart failure and diabetes had almost three times the adjusted odds
of consuming more than the recommended sodium intake.
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Discussion
The purpose of the study was to identify characteristics of patients with heart failure who
had higher than recommended 24-hour urine sodium excretion. In this study, we used 24hour sodium excretion as an estimate of dietary sodium intake, or adherence to sodium
guidelines. Considering possible predictors drawn from the WHO adherence model, the
three most important predictors of higher sodium excretion were patient- and conditionrelated factors. Patients with heart failure who were obese or had diabetes and those who
were cognitively intact were more likely to excrete higher amounts of sodium.
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The association between higher sodium and obesity is most likely explained by both direct
and indirect effects.31,47 One explanation for the relationship between obesity and higher
sodium consumption is that high-calorie foods often contain high sodium.48 Increased
dietary sodium intake is directly correlated with increased calorie consumption.30,49
According to the Salted Food Addictive Hypothesis, salted foods act in the brain like an
opiate agonist, producing a hedonistic reward, which becomes associated with foods being
judged as “delicious” or “flavorful.”47 Withdrawal of salty foods acts like an opiate receptor
withdrawal and causes perceived “cravings” for salted foods.47 Over time, daily
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consumption of salted foods can produce an addiction, which escalates and can stimulate
overeating.50
The association between high sodium intake and obesity has also been found in rat animal
models51 and has a physiological explanation: chronic salt overload induces adipocyte
hypertrophy, which enhances insulin sensitivity for glucose uptake and insulin-induced
glucose metabolism.51 Song and colleagues report a direct effect between sodium intake and
risk of being overweight in humans, after adjusting for energy, water, and soda
consumption;31 however, their study sample did not include patients with heart failure,
hypertension or diabetes. The relationship between obesity and sodium consumption is
consistent with results of our previous study in which we found that patients with heart
failure who were overweight had a four-fold increased odds of consuming more than 3000
mg of sodium per day.52
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Other lifestyle factors may help explain the relationship between obesity and sodium
consumption. Processed and packaged foods are naturally high in sodium because sodium is
a natural preservative that increases the shelf life of foods. Patients with heart failure often
feel fatigued and may have less energy to dedicate to the purchase and preparation of lowsodium food. Originally, we thought that purchasing fresh produce and meat may be
prohibitively expensive for patients on fixed or limited incomes; however, income was not a
statistically significant predictor of higher sodium excretion. Another important question is
whether the guidelines should recommend varying amounts of sodium intake for people
with heart failure with different body weight and other clinical characteristics. According to
Gupta and colleagues, reporting in 2012, there is still uncertainty as to whether dietary
sodium intake recommendations should be individualized.9
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Diabetes was a strong predictor of higher than recommended sodium intake. This may be
explained by the fact that any form of kidney disease in which tubular reabsorption of
filtered sodium does not match the filtered load plus dietary intake can cause renal sodium
wasting (i.e. hyperfiltration occurring in earlier stages of diabetic nephropathy). The finding
that diabetes is a predictor of higher sodium intake is consistent with a previous analysis in
which patients with diabetes were four times as likely to consume more than 4 g of sodium
per day over time.52 This finding may be explained by the association between diabetes and
obesity, in which case diabetes is acting as a marker of obesity.
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In the literature, associations between mild cognitive impairment and heart failure self-care
behaviors are mixed.1,53,54 Mild cognitive impairment has been associated with worse selfcare management55,56 probably because of an inability to perform the complex decisionmaking required to manage signs and symptoms. An association between cognitive
impairment and poorer self-care maintenance such as eating a low sodium diet has not been
reported. In a study by Cameron and colleagues, the majority of patients (73%) had
unrecognized or subclinical cognitive impairment and were as likely to engage in healthpromoting behaviors, such as daily weighing, as those without cognitive impairment.56
Dickson and colleagues reported that poorer cognition was associated with better self-care
behaviors among patients with heart failure in a mixed-methods study.57 It is important to
note that these prior studies focused on the subjective assessment of multiple self-care
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behaviors and not exclusively on dietary sodium. Further, there were considerable
differences across studies in the methods of measuring cognition that may, in part, explain
differences in study findings.57
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While it may be assumed that patients with mild cognitive impairment will not be able to
follow a low-sodium diet that was not the case in this study. Patients who were cognitively
intact had more than double the odds of consuming higher than recommended sodium levels
compared to patients with cognitive impairment. This seemingly counter-intuitive finding
may be explained by the fact that patients with cognitive impairment often have caregivers
who make and provide their meals. Patients who are cognitively intact may be more selfreliant in making dietary decisions. This finding could also be explained by the rigidity that
is associated with cognitive impairment.58,59 Rigidity refers to the tendency to form and
repeat particular behaviors; eating the same foods is one form of rigidity. We cannot confirm
either of these hypotheses because we did not collect data on caregivers or rigidity
associated with specific dietary choices in this study.
Many patients with heart failure struggle to consume levels of sodium that are considered
moderate. In a study of adults with heart failure from the Southern US, only 33% of
individuals consumed 2000 mg/day or less with the wide range of 522–9251 mg/day.60
Likewise, based on 24-hour urinary sodium excretion levels, another study reported that
34% of the sample was compliant with recommendations to consume less than 3000 mg/day
and only 15% consumed less than 2000 mg/day.10
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Recently, sodium restriction for patients with heart failure has been questioned due to wide
variation in the study protocols, study samples, fluid intake, measurement of sodium intake
and compliance.13 Some studies have even questioned any sodium restriction;61,62 however,
this was largely due to a very rigid definition of sodium intake (80 mmol/day).61 Paterna and
colleagues recommend a normal sodium diet, defined as 120 mmol/ day (about 2800 mg/
day) 61,62 which is consistent with the recommendation of <3 g a day for patients with Class
C and D heart failure.13 Overall, the message across these studies and a recent review by
Gupta and colleagues is consistent— high sodium intake is not optimal for patients with
heart failure because excessive sodium intake is associated with fluid retention; however, the
lower-dose range of sodium intake needs to be better defined, and possibly individualized to
patients in future studies.9
Strengths and limitations
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One of the strengths of this study was the repeated measures of sodium excretion on the
same individuals over a six-month period. Multivariate statistical methods were used for
these repeated measures to account for the correlation of measures within an individual,
which reduced measurement error and individual variability. The use of longitudinal data in
this study also provided a clearer picture of how well patients followed a low-sodium diet
over an extended period of time, instead of one point in time. Another strength of the study
is that we used robust and transparent imputation methods to address potential bias from
incomplete data.37,39
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The study also had several limitations including the fact that this was a secondary analysis of
a dataset that did not include measures of sodium intake. Data from carefully controlled
studies show that at least seven days of direct measurement of sodium intake and excretion
in the urine are needed to achieve correlations of 0.8,63 which implies that food records and
urine excretion provide complementary information about sodium intake. The relationship
between sodium intake and excretion is analogous to fasting blood glucose and hemoglobin
A1c in diabetic patients. These two measures provide similar, but different, information
about dietary adherence in patients with diabetes. In this study, our intention was not to
precisely estimate sodium intake over the previous 24 hours, but to estimate general
adherence to dietary recommendations. For our purposes, 24-hour sodium excretion was the
best available marker of dietary sodium consumption.
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Another limitation of this study was that patients in this sample were on loop diuretics,
which enhance urinary excretion of sodium by inhibiting tubular reabsorption at the thick
ascending limb of the Loop of Henle, in the nephron. Arcand and colleagues, in 2010, found
no statistically significant relationship between 24-hour urine sodium excretion and sodium
intake from food records in patients with heart failure on a loop diuretic; however, they
reported significant correlations for non-heart failure cardiac patients and for patients with
heart failure who were not prescribed a loop diuretic.64 While informative, limitations of the
Arcand study were that it used a cross-sectional, correlational design in a young, relatively
small sample of patients with heart failure in which other relevant variables that may explain
the differences in sodium excretion were not controlled. Though there may be some
imprecision from using urinary sodium excretion as a measure of dietary sodium intake for
patients on loop diuretics, it is still considered the best measure for patients with heart
failure.10,30,65 In addition, we statistically controlled for diuretic use.
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There are inherent limitations to a secondary data analysis, including the fact that this study
was limited by the demographics and size of the original sample. For example this sample
was younger than most other community-dwelling samples of patients with heart failure so
the results may not be generalizable to older adults with heart failure. There may be
additional predictors of higher sodium intake that were not measured in the parent study,
such as fluid intake, and thus could not be controlled for. In addition, while it was a strength
that we used four of the five dimensions of adherence in the WHO model, the dimensions
were not measured comprehensively. For instance, due to the sample size, we were
restricted to including only variables that were both conceptually consistent with the WHO
dimensions as well as statistically associated with sodium excretion in the final model. Some
dimensions may not have been fully captured by the variables selected.
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Conclusion
Patients with heart failure who are cognitively intact, those who have diabetes or are obese
are at risk for consuming more sodium than recommended. The 2013 report of the AHA
guidelines for the management of heart failure recommends reasonable sodium restriction
for patients with symptomatic heart failure to reduce congestive symptoms13 and the HFSA
guidelines recommend that all patients with heart failure be provided with dietary
instruction.5 Sodium dietary instructions should be contextualized within a longer
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conversation with patients about their general sodium intake. Further research may support
identifying higher risk patients and intervening to help them decrease their sodium intake.
Ultimately interventions around dietary sodium intake may help decrease the risk of
decompensation and re-hospitalization for patients with heart failure.11,66

Acknowledgments
The authors gratefully acknowledge Russell Localio at the University of Pennsylvania School of Medicine, for his
substantial contribution to the mixed-effects and imputation methods of this paper. They also appreciate his
commitment to interdisciplinary collaboration and mentorship of students. The authors would also like to
acknowledge Thomas A Gillespie for scoring the NYHA interviews.
Funding

Author Manuscript

This work was funded by a grant from the National Heart, Lung & Blood Institute (RO1 HL084394-01A1) and by
the Philadelphia Veterans Affairs Medical Center, Veterans Integrated Services Networks 4 Mental Illness
Research, Education, and Clinical Center. The authors gratefully acknowledge the pre-doctoral funding for Ruth
Masterson Creber provided by the National Hartford Centers of Geriatric Nursing Excellence Patricia G Archbold
Scholarship program; the New Courtland Center for Transitions and Health and the Center for Integrative Science
in Aging NIH/NINR (T32-NR009356) in 2012; and an NIH/NINR Ruth L. Kirschstein National Research Service
Award (F31NR014086-01).

References

Author Manuscript
Author Manuscript

1. Riegel B, Lee CS, Dickson VV. Self care in patients with chronic heart failure. Nat Rev Cardiol.
2011; 19:644–54. [PubMed: 21769111]
2. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA
2005 guidelines for the diagnosis and management of heart failure in adults. J Am Coll Cardiol.
2009; 53:e1–e90. [PubMed: 19358937]
3. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and
management of chronic heart failure in the adult: A report of the American College of Cardiology/
American Heart Association Task Force on practice guidelines (Writing Committee to update the
2001 guidelines for the evaluation and management of heart failure): Developed in collaboration
with the American College of Chest Physicians and the International Society for Heart and Lung
Transplantation: Endorsed by the Heart Rhythm Society. Circulation. 2005; 112:e154–e235.
[PubMed: 16160202]
4. Riegel B, Moser DK, Powell M, et al. Nonpharmacologic care by heart failure experts. J Card Fail.
2006; 12:149–153. [PubMed: 16520265]
5. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice
guideline. J Card Fail. 2010; 16:e1–e194. [PubMed: 20610207]
6. Tsuyuki RT, McKelvie RS, Arnold JM, et al. Acute precipitants of congestive heart failure
exacerbations. Arch Intern Med. 2001; 161:2337–2342. [PubMed: 11606149]
7. Lennie TA, Worrall-Carter L, Hammash M, et al. Relationship of heart failure patients’ knowledge,
perceived barriers, and attitudes regarding low-sodium diet recommendations to adherence. Prog
Cardiovasc Nurs. 2008; 23:6–11. [PubMed: 18326994]
8. Chung ML, Moser DK, Lennie TA, et al. Gender differences in adherence to the sodium-restricted
diet in patients with heart failure. J Card Fail. 2006; 12:628–634. [PubMed: 17045182]
9. Gupta D, Georgiopoulou VV, Kalogeropoulos AP, et al. Dietary sodium intake in heart failure.
Circulation. 2012; 126:479–85. [PubMed: 22825409]
10. Lennie TA, Song EK, Wu JR, et al. Three gram sodium intake is associated with longer event-free
survival only in patients with advanced heart failure. J Card Fail. 2011; 17:325–330. [PubMed:
21440871]
11. Arcand J, Ivanov J, Sasson A, et al. A high-sodium diet is associated with acute decompensated
heart failure in ambulatory heart failure patients: A prospective follow-up study. Am J Clin Nutr.
2011; 93:332–337. [PubMed: 21084647]

Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.

Creber et al.

Page 11

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

12. United States Department of Agriculture and United States Department of Health and Services.
Dietary guidelines for Americans, 2010. 7. Washington, DC: United States Government Printing
Office; 2010.
13. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart
failure: A report of the American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 62:e147–239. [PubMed: 23747642]
14. Heo S, Lennie TA, Moser DK, et al. Heart failure patients’ perceptions on nutrition and dietary
adherence. Eur J Cardiovasc Nurs. 2009; 8:323–328. [PubMed: 19589729]
15. Van der Wal MH, Jaarsma T, Moser DK, et al. Compliance in heart failure patients: The
importance of knowledge and beliefs. Eur Heart J. 2006; 27:434–440. [PubMed: 16230302]
16. Bentley B, De Jong MJ, Moser DK, et al. Factors related to nonadherence to low sodium diet
recommendations in heart failure patients. Eur J Cardiovasc Nurs. 2005; 4:331–336. [PubMed:
15935733]
17. Heo S, Moser DK, Lennie TA, et al. Gender differences in and factors related to self-care
behaviors: A cross-sectional, correlational study of patients with heart failure. Int J Nurs Stud.
2008; 45:1807–1815. [PubMed: 18674762]
18. World Health Organization (WHO). Adherence to long-term therapies: Evidence for action.
Geneva, Switzerland: WHO; 2003. p. 1-211.
19. Riegel B, Lee CS, Ratcliffe SJ, et al. Predictors of objectively measured medication nonadherence
in adults with heart failure. Circ Heart Fail. 2012; 5:430–436. [PubMed: 22647773]
20. Rickham PP. Human Experimentation. Code of Ethics of the World Medical Association.
Declaration of Helsinki. Brit Med J. 1964; 2:177. [PubMed: 14150898]
21. Riegel B, Moelter ST, Ratcliffe SJ, et al. Excessive daytime sleepiness is associated with poor
medication adherence in adults with heart failure. J Card Fail. 2011; 17:340–348. [PubMed:
21440873]
22. Folstein M, Folstein S, McHugh P. Mini-mental state: A practical method for grading the cognitive
state of patients for the clinician. J Psychiatr Res. 1975; 12:189–198. [PubMed: 1202204]
23. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in
longitudinal studies: Development and validation. J Chronic Dis. 1987; 40:373–383. [PubMed:
3558716]
24. Riegel B, Carlson B. Is individual peer support a promising intervention for persons with heart
failure? J Cardiovasc Nurs. 2004; 19:174–183. [PubMed: 15191260]
25. Riegel B, Carlson B, Kopp Z, et al. Effect of a standardized nurse case-management telephone
intervention on resource use in patients with chronic heart failure. Arch Intern Med. 2002;
162:705–712. [PubMed: 11911726]
26. Riegel B, Carlson B, Glaser D, et al. Which patients with heart failure respond best to
multidisciplinary disease management? J Card Fail. 2000; 6:290–299. [PubMed: 11145753]
27. Kubo SH, Schulman S, Starling RC, et al. Development and validation of a patient questionnaire to
determine New York Heart Association classification. J Card Fail. 2004; 10:228–235. [PubMed:
15190533]
28. European Food Safety Authority. Opinion of the scientific panel on dietetic products, nutrition and
allergies on a request from the commission related to the tolerable upper intake level of sodium.
EFSA Journal. 2005; 209:1–26.
29. Espeland MA, Kumanyika S, Wilson AC, et al. Statistical issues in analyzing 24-hour dietary
recall and 24-hour urine collection data for sodium and potassium intakes. Am J Epidemiol. 2001;
153:996–1006. [PubMed: 11384956]
30. Korhonen MH, Jarvinen RM, Sarkkinen ES, et al. Effects of a salt-restricted diet on the intake of
other nutrients. Am J Clin Nutr. 2000; 72:414–420. [PubMed: 10919936]
31. Song HJ, Cho YG, Lee H-J. Dietary sodium intake and prevalence of overweight in adults.
Metabolism. 2013; 62:703–708. [PubMed: 23357528]
32. Bingham SA, Williams R, Cole TJ, et al. Reference values for analytes of 24-h urine collections
known to be complete. Ann Clin Biochem. 1988; 25:610–619. [PubMed: 3267076]

Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.

Creber et al.

Page 12

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

33. Intersalt Cooperative Research Group. Intersalt: An international study of electrolyte excretion and
blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative
Research Group. Brit Med J. 1988; 297:319–328. [PubMed: 3416162]
34. Day NE, McKeown N, Wong MY, et al. Epidemiological assessment of diet: A comparison of a 7day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and
sodium. Int J Epidemiol. 2001; 30:309–317. [PubMed: 11369735]
35. Institute of Medicine. Dietary reference intakes: Applications in dietary assessment. Washington,
DC: National Academies Press; 2000.
36. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced
heart failure. Am J Cardiol. 2006; 97:1759–1764. [PubMed: 16765130]
37. Little, R.; Rubin, DB. Statistical analysis with missing data. 2. New York: John Wiley & Sons;
2002.
38. Little, RJ.; Rubin, DB. Statistical analysis with missing data. New York: John Wiley & Sons Inc;
1987.
39. Rubin, DB. Multiple imputation for nonresponse in surveys. New York, NY: John Wiley & Sons,
Inc; 1987.
40. Kenward M, Carpenter J. Multiple imputation: Current perspectives. Stat Methods Med Res. 2007;
16:199–218. [PubMed: 17621468]
41. Royston P. Multiple imputation of missing values. Stata Journal. 2004; 4:227–241.
42. Royston P. Multiple imputation of missing values: Update of ice. Stata Journal. 2005; 5:527–536.
43. Fitzmaurice, G.; Laird, N.; Ware, J. Applied longitudinal analysis. New York: Wiley; 2004.
44. World Health Organization. Overview: Medication adherence–where are we today?. Geneva,
Switzerland: WHO; 2006. p. 7-16.
45. Bodner TE. What improves with increased missing data imputations? Struct Equ Modeling. 2008;
15:651–675.
46. StataCorp. Stata statistical software: Release 11.2. College Station, Texas: StataCorp LP; 2009.
47. Cocores JA, Gold MS. The salted food addiction hypothesis may explain overeating and the
obesity epidemic. Med Hypotheses. 2009; 73:892–899. [PubMed: 19643550]
48. Centers for Disease Control and Prevention. Sodium intake among adults - United States, 2005–
2006. MMWR Morb Mortal Wkly Rep. 2010; 59:746–749. [PubMed: 20577156]
49. Morris CD. Effect of dietary sodium restriction on overall nutrient intake. Am J Clin Nutr. 1997;
65:687S–691S. [PubMed: 9022566]
50. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006; 49:59–75.
[PubMed: 17046432]
51. Fonseca-Alaniz MH, Takada J, Andreotti S, et al. High sodium intake enhances insulin-stimulated
glucose uptake in rat epididymal adipose tissue. Obesity (Silver Spring). 2008; 16:1186–1192.
[PubMed: 18369340]
52. Masterson Creber RM, Lee CS, Lennie TA, et al. Using growth mixture modeling to identify
classes of sodium adherence in adults with heart failure. J Cardiovasc Nurs. 2014; 29:209–217.
[PubMed: 23416937]
53. Riegel B, Lee CS, Dickson VV, et al. An update on the self-care of heart failure index. J
Cardiovasc Nurs. 2009; 24:485–497. [PubMed: 19786884]
54. Riegel B, Carlson B, Moser DK, et al. Psychometric testing of the self-care of heart failure index. J
Card Fail. 2004; 10:350–360. [PubMed: 15309704]
55. Lee CS, Gelow JM, Bidwell JT, et al. Blunted responses to heart failure symptoms in adults with
mild cognitive dysfunction. J Cardiovasc Nurs. 2013; 28:534–540. [PubMed: 23013837]
56. Cameron J, Worrall-Carter L, Page K, et al. Does cognitive impairment predict poor self-care in
patients with heart failure? Eur J Heart Fail. 2010; 12:508–515. [PubMed: 20354031]
57. Dickson V, Lee CS, Riegel B. How do cognitive function and knowledge affect heart failure selfcare? J Mix Methods Res. 2011; 5:167–189.
58. Litvan I, Mohr E, Williams J, et al. Differential memory and executive functions in demented
patients with Parkinson’s and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1991; 54:25–
29. [PubMed: 2010755]

Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.

Creber et al.

Page 13

Author Manuscript
Author Manuscript

59. Schultz PW, Searleman A. Rigidity of thought and behavior: 100 years of research. Genet Soc Gen
Psychol Monogr. 2002; 128:165–207. [PubMed: 12194421]
60. Frediani JK, Reilly CM, Higgins M, et al. Quality and adequacy of dietary intake in a southern
urban heart failure population. J Cardiovasc Nurs. 2013; 28:119–128. [PubMed: 22343212]
61. Paterna S, Parrinello G, Cannizzaro S, et al. Medium term effects of different dosage of diuretic,
sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently
compensated heart failure. Am J Cardiol. 2009; 103:93–102. [PubMed: 19101237]
62. Paterna S, Gaspare P, Fasullo S, et al. Normal-sodium diet compared with low-sodium diet in
compensated congestive heart failure: Is sodium an old enemy or a new friend? Clin Sci (Lond).
2008; 114:221–230. [PubMed: 17688420]
63. Bates, C.; Thurnham, D.; Bingham, S., et al. Bio- chemical markers of nutrient intake. Oxford:
Oxford University Press; 1997.
64. Arcand J, Floras JS, Azevedo E, et al. Evaluation of two methods for sodium intake assessment in
cardiac patients with and without heart failure: The confounding effect of loop diuretics. Am J
Clin Nutr. 2010; 93:535–541. [PubMed: 21191141]
65. O’Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of
cardiovascular events. JAMA. 2011; 306:2229–2238. [PubMed: 22110105]
66. Paul S. Hospital discharge education for patients with heart failure: What really works and what is
the evidence? Crit Care Nurse. 2008; 28:66–82. [PubMed: 18378729]

Author Manuscript
Author Manuscript
Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.

Creber et al.

Page 14

Author Manuscript

Implications for practice
•

Patients who have diabetes, are obese or are cognitively intact might be at risk
for consuming more sodium than recommended.

•

Further research should identify patients and intervene to help them reduce high
sodium consumption with tailored dietary interventions.
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World Health Organization five dimensions of adherence model.
Dimension of adherence

Variables used in this study

Social/economic factors

Race, income, highest level of education

Therapy-related factors

Diuretic (loop or thiazide)

Patient-related factors

Gender, age, body mass index, cognitive status

Condition-related factors

Heart failure type (diastolic or systolic), diabetes, hypertension, etiology (ischemic or non-ischemic)

Health-system factors

Not available in this study
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100

Female

175

White

137
45

Enough to meet needs

Less than needed

164
50

Class III

Class IV
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91
63
29
8

≤40 mg/day

>40 and ≤120 mg/day

>120 mg/day

Hydrochlorothiazide (mg/day)

177

Non-ischemic

BMI (n=279)b

102

Ischemic

Heart failure etiology (n=279)b

183

Furosemide equ. (mg/day) n=183

Diuretic usea

66

Class I/II

NYHA functional class

98

More than needed

Income

105

Black/other

Race

180

115

165

64

36

3

16

34

50

18

59

23

16

49

35

62

38

36

64

59

41

Total %

Male

Gender

≥65 years

<65 years

Age

Variables

3.05 (0.03)

3.11 (0.03)

3.30 (0.53)

3.01 (0.27)

3.33 (0.27)

2.97 (0.14)

3.07 (0.15)

3.28 (0.06)

3.02 (0.03)

3.03 (0.04)

3.35 (0.05)

3.21 (0.03)

2.75 (0.03)

3.30 (0.04)

2.95 (0.02)

2.81 (0.03)

3.23 (0.24)

2.61 (0.03)

3.08 (0.03)

Mean UrNa g/day (SE)

66

35

1

72

18

49

33

11

51

38

67

33

39

61

52

48

61

38

3

69

15

68

17

19

48

33

63

37

34

66

37

63

Na+ excretion levels Within or Higher

0.625

0.400

0.703

0.009

0.269

0.597

0.425

0.022

p-value

Demographic, social and clinical characteristics of patients, mean 24-hour urine sodium (Na+) samples and whether they were within or higher than
recommended HFSA guidelines.

Author Manuscript

Table 2
Creber et al.
Page 16

Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.
86

Diastolic or mixed

101
30

Moderate

High

173

No

99

No

58

No

107
165

Cognitively impaired

Not cognitively impaired

Cognition

222

Yes

COPD

181

Yes

Hypertension

107

Yes

Diabetes

149

Low

Charlson co-morbidity

194

Systolic

Type of heart failure

151

High school graduate

More than high school

27
102

Less than high school

61

39

21

79

35

65

62

38

11

36

53

31

69

54

36

10

48

26

3.14 (0.03)

2.90 (0.02)

3.20 (0.03)

2.53 (0.06)

3.07 (0.03)

3.06 (0.02)

2.72 (0.04)

3.57 (0.05)

3.26 (0.09)

3.13 (0.06)

2.96 (0.04)

3.19 (0.05)

3.00 (0.02)

3.12 (0.03)

3.05 (0.03)

2.65 (0.07)

3.53 (0.02)

2.86 (0.05)

2.39 (0.03)

53

47

27

73

35

65

77

23

7

37

56

24

76

50

39

11

35

27

38

72

28

19

81

37

63

53

47

15

35

50

31

69

58

35

7

55

27

18

Na+ excretion levels Within or Higher

0.004

0.129

0.729

0.001

0.268

0.475

0.271

0.001

p-value

BMI: body mass index; COPD: chronic obstructive pulmonary disorder; equ.: equivalent; NYHA: New York Heart Association; SE: standard error, UrNa: urine sodium.

Sample size for variables with missing values.

b

Diuretic use: This only includes information on patients who were on diuretic medications. The proportions are only for those prescribed furosemide (n=183), not the entire population sample.

a

133

Obese (30+)

Highest level of education

73

26

74

Overweight (25–29)
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Normal (18–24)

Author Manuscript
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Author Manuscript

Total %

Author Manuscript
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Table 3

Author Manuscript

Factors associated with higher sodium excretion (n=280).
Variables

p-value

Adjusted OR

95% CI

Cognitively impaired

1.00

Reference

Cognitively intact

2.22

1.09–4.53

Normal (18–24)

1.00

Reference

Overweight (25–29)

1.79

0.75–4.25

0.187

Obese (30+)

2.90

1.15–4.25

<0.001

No

1.00

Reference

Yes

2.80

1.33–5.89

Female

1.00

Reference

Male

1.16

0.54–2.51

≥65 years

1.00

Reference

<65 years

1.95

0.97–3.90

0.059

Hypertension

0.51

0.25–1.04

0.068

Income

1.11

0.67–1.84

0.696

Diuretic use

1.05

0.48–2.33

0.897

Heart failure etiology

0.72

0.31–1.67

0.438

Type of heart failure (systolic, diastolic, mixed)

1.24

0.78–1.98

0.351

Education

1.14

0.67–1.96

0.607

Race

1.17

0.57–2.42

0.663

Cognition

0.028

Body mass index

Diabetes

0.007

Author Manuscript

Gender

0.703

Age

Author Manuscript

OR: odds ratio; CI: confidence interval.
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